Mapping the course of neurodegeneration

Written by Jenny Straiton (Assistant Editor)

New research provides a possible explanation as to why neurodegenerative disorders originate in one distinct region, answers that show potential for the development of new treatments. In diseases such as Alzheimer’s and Parkinson’s, the progress of neurodegeneration follows a distinctive path, always starting in the same place; for Alzheimer’s it’s the temporal lobe, for Parkinson’s it’s the dopaminergic neurons of the substantia nigra. Until now, the reason for this selective vulnerability has been unknown, as it had been assumed that brain cells were genetically identical. “This has been a big open question in neuroscience, particularly in various neurodegenerative diseases,” commented...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!